About Us

Glaucoma is a group of eye conditions that damage the optic nerve, often associated with increased intraocular pressure (IOP). It is one of the leading causes of irreversible blindness worldwide, affecting approximately 60 million people globally. The management of glaucoma typically involves a combination of medications, laser treatments, and surgical interventions aimed at lowering IOP and preserving optic nerve health.

While the gold standard treatment for glaucoma is lowering the eye pressure, fortifying the optic nerve to withstand glaucomatous damage through neuroprotective efforts holds potential as a complement to glaucoma treatment. We seek to provide glaucoma vitamin solutions to patients in response to growing research regarding dietary supplements' ability to provide neuroprotection.

Pyruvate and Nicotinamide, have been explored for their potential benefits in supporting optic nerve health. Pyruvate is a key intermediate in cellular metabolism and has been studied for its role in enhancing cellular resilience. Nicotinamide, a form of vitamin B3, has been shown to have neuroprotective effects and helps in reducing the risk of retinal ganglion cell death, a hallmark of glaucoma.

It is essential for patients to consult with their healthcare providers before starting any new vitamin regimen, particularly those with glaucoma. A tailored approach that considers individual health needs and existing treatments is crucial for optimizing outcomes. While vitamins and supplements can provide supportive care, they should not replace prescribed glaucoma therapies.